BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 21111392)

  • 1. The role of the community pharmacist in fulfilling information needs of patients starting oral antidiabetics.
    Lamberts EJ; Bouvy ML; van Hulten RP
    Res Social Adm Pharm; 2010 Dec; 6(4):354-64. PubMed ID: 21111392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The General Practitioner-Pharmacist Collaboration (GPPC) study: a randomised controlled trial of clinical medication reviews in community pharmacy.
    Bryant LJ; Coster G; Gamble GD; McCormick RN
    Int J Pharm Pract; 2011 Apr; 19(2):94-105. PubMed ID: 21385240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medication adherence program: adherence challenges and interventions in type 2 diabetes.
    Odegard PS; Carpinito G; Christensen DB
    J Am Pharm Assoc (2003); 2013; 53(3):267-72. PubMed ID: 23699675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perceived barriers to provision of medication therapy management services (MTMS) and the likelihood of a pharmacist to work in a pharmacy that provides MTMS.
    Blake KB; Madhavan SS
    Ann Pharmacother; 2010 Mar; 44(3):424-31. PubMed ID: 20179254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An intervention to develop repeat prescribing in community pharmacy.
    Saastamoinen LK; Klaukka TJ; Ilomäki J; Enlund H
    J Clin Pharm Ther; 2009 Jun; 34(3):261-5. PubMed ID: 19646075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacist roles in the management of patients with type 2 diabetes.
    Sisson E; Kuhn C
    J Am Pharm Assoc (2003); 2009; 49 Suppl 1():S41-5. PubMed ID: 19801364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ontario family physician readiness to collaborate with community pharmacists on drug therapy management.
    Pojskic N; Mackeigan L; Boon H; Ellison P; Breslin C
    Res Social Adm Pharm; 2011 Mar; 7(1):39-50. PubMed ID: 21397880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Community pharmacists' prescription intervention practices--exploring variations in practice in Norwegian pharmacies.
    Mandt I; Horn AM; Ekedahl A; Granas AG
    Res Social Adm Pharm; 2010 Mar; 6(1):6-17. PubMed ID: 20188324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intern pharmacists as change agents to improve the practice of nonprescription medication supply: provision of salbutamol to patients with asthma.
    Schneider CR; Everett AW; Geelhoed E; Padgett C; Ripley S; Murray K; Kendall PA; Clifford RM
    Ann Pharmacother; 2010; 44(7-8):1319-26. PubMed ID: 20571101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evaluation of a community pharmacy-based rural asthma management service.
    Saini B; Filipovska J; Bosnic-Anticevich S; Taylor S; Krass I; Armour C
    Aust J Rural Health; 2008 Apr; 16(2):100-8. PubMed ID: 18318852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a pilot study to influence medication adherence of patients with diabetes mellitus type-2 by the pharmacy.
    Adhien P; van Dijk L; de Vegter M; Westein M; Nijpels G; Hugtenburg JG
    Int J Clin Pharm; 2013 Dec; 35(6):1113-9. PubMed ID: 23942987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Community pharmacist perceptions of clinical medication reviews.
    Bryant L; Coster G; McCormick R
    J Prim Health Care; 2010 Sep; 2(3):234-42. PubMed ID: 21069119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacists' and consumers' viewpoints on counselling on prescription medicines in Australian community pharmacies.
    Puspitasari HP; Aslani P; Krass I
    Int J Pharm Pract; 2010 Aug; 18(4):202-8. PubMed ID: 20636671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of community pharmacists in providing clinical medication reviews.
    Laaksonen R; Duggan C; Bates I
    Ann Pharmacother; 2010; 44(7-8):1181-90. PubMed ID: 20571102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacists' experience of conflict in community practice.
    Austin Z; Gregory PA; Martin JC
    Res Social Adm Pharm; 2010 Mar; 6(1):39-48. PubMed ID: 20188327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nontraditional or noncentralized models of diabetes care: medication therapy management services.
    Chawla S
    J Fam Pract; 2011 Nov; 60(11 Suppl):S12-8. PubMed ID: 22336920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The community pharmacist and the problem of excessive drinkers].
    Pouyet-Poulet E; Sauvant MP; Pépin D; Planche R
    Sante Publique; 2001 Sep; 13(3):237-48. PubMed ID: 11826843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medicine-related questions handled by community pharmacists: an exploratory study.
    Rutter PM; Warren S; Rutter J
    Int J Pharm Pract; 2009 Oct; 17(5):313-5. PubMed ID: 20214274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The current and future roles of community pharmacists: views and experiences of patients with type 2 diabetes.
    Twigg MJ; Poland F; Bhattacharya D; Desborough JA; Wright DJ
    Res Social Adm Pharm; 2013; 9(6):777-89. PubMed ID: 23127392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medication therapy management services in West Virginia: pharmacists' perceptions of educational and training needs.
    Blake KB; Madhavan SS; Scott VG; Meredith Elswick BL
    Res Social Adm Pharm; 2009 Jun; 5(2):182-8. PubMed ID: 19524865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.